Udyan Bio-Tech India Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 2.95 M
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
- Revenue Growth %
- Profit Growth -1680.95%
- Ebitda 2.23%
- Net Worth -0.09%
- Total Assets -12.88%
About Udyan Bio-Tech India
Udyan Bio-Tech India Private Limited (UBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 September 1995 and has a history of 29 years and four months. Its registered office is in Hisar, Haryana, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 2.95 M.
The company currently has active open charges totaling ₹3.50 Cr.
Sandeepa Singh and Surender Singh serve as directors at the Company.
Company Details
-
Location
Hisar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24129HR1995PTC032858
-
Company No.
032858
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Sep 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Udyan Bio-Tech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeepa Singh
|
Director | 06-Nov-2001 | Current |
|
Surender Singh
|
Director | 02-Aug-2008 | Current |
Financial Performance of Udyan Bio-Tech India.
Udyan Bio-Tech India Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1680.95% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Udyan Bio-Tech India?
In 2020, Udyan Bio-Tech India had a promoter holding of 1.93% and a public holding of 98.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vv Associates Private LimitedSurender Singh is a mutual person
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2005 | State Bank Of India | ₹3.50 Cr | Open |
How Many Employees Work at Udyan Bio-Tech India?
Unlock and access historical data on people associated with Udyan Bio-Tech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Udyan Bio-Tech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Udyan Bio-Tech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
